These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 3729018)
1. Oxygen concentrations required for reductive defluorination of halothane by rat hepatic microsomes. Lind RC; Gandolfi AJ; Sipes IG; Brown BR; Waters SJ Anesth Analg; 1986 Aug; 65(8):835-9. PubMed ID: 3729018 [TBL] [Abstract][Full Text] [Related]
2. Oxidative defluorination of 1,1,1,2-tetrafluoroethane by rat liver microsomes. Olson MJ; Reidy CA; Johnson JT; Pederson TC Drug Metab Dispos; 1990; 18(6):992-8. PubMed ID: 1981550 [TBL] [Abstract][Full Text] [Related]
3. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin. Baker MT; Nelson RM; Van Dyke RA Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335 [TBL] [Abstract][Full Text] [Related]
4. Oxidation of 1,1,1,2-tetrafluoroethane in rat liver microsomes is catalyzed primarily by cytochrome P-450IIE1. Olson MJ; Kim SG; Reidy CA; Johnson JT; Novak RF Drug Metab Dispos; 1991; 19(2):298-303. PubMed ID: 1676626 [TBL] [Abstract][Full Text] [Related]
5. Reductive metabolism of halothane by cytochrome P450 isoforms in rats and humans. Chow T; Imaoka S; Hiroi T; Funae Y Res Commun Mol Pathol Pharmacol; 1996 Sep; 93(3):363-74. PubMed ID: 8896047 [TBL] [Abstract][Full Text] [Related]
6. Characterization of halothane oxidation by hepatic microsomes and purified cytochromes P-450 using a gas chromatographic mass spectrometric assay. Gruenke LD; Konopka K; Koop DR; Waskell LA J Pharmacol Exp Ther; 1988 Aug; 246(2):454-9. PubMed ID: 3404442 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes. Ferrara R; Tolando R; King LJ; Manno M Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458 [TBL] [Abstract][Full Text] [Related]
8. Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents. Van Dyke RA; Gandolf AJ Drug Metab Dispos; 1976; 4(1):40-4. PubMed ID: 3400 [TBL] [Abstract][Full Text] [Related]
9. Stimulatory effects of halothane and isoflurane on fluoride release and cytochrome P-450 loss caused by metabolism of 2-chloro-1,1-difluoroethene, a halothane metabolite. Baker MT; Bates JN; Leff SV Anesth Analg; 1987 Nov; 66(11):1141-7. PubMed ID: 2889401 [TBL] [Abstract][Full Text] [Related]
10. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate. Haaparanta T; Halpert J; Glaumann H; Gustafsson JA Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054 [TBL] [Abstract][Full Text] [Related]
11. Halothane hepatotoxicity and reductive metabolism of halothane in acute experimental liver injury in rats. Nomura F; Hatano H; Iida S; Ohnishi K Anesth Analg; 1988 May; 67(5):448-52. PubMed ID: 3364763 [TBL] [Abstract][Full Text] [Related]
12. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice. Dekant W; Assmann M; Urban G Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828 [TBL] [Abstract][Full Text] [Related]
13. The in vitro metabolism of halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) by hepatic microsomal cytochrome P-450. Karashima D; Hirokata Y; Shigematsu A; Furukawa T J Pharmacol Exp Ther; 1977 Nov; 203(2):409-16. PubMed ID: 909072 [TBL] [Abstract][Full Text] [Related]
14. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH; Mannering GJ Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917 [TBL] [Abstract][Full Text] [Related]
15. The effect of cimetidine on anesthetic metabolism and toxicity. Wood M; Uetrecht J; Phythyon JM; Shay S; Sweetman BJ; Shaheen O; Wood AJ Anesth Analg; 1986 May; 65(5):481-8. PubMed ID: 3963434 [TBL] [Abstract][Full Text] [Related]
16. Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver. Foureman GL; Harris C; Guengerich FP; Bend JR J Pharmacol Exp Ther; 1989 Feb; 248(2):492-7. PubMed ID: 2918465 [TBL] [Abstract][Full Text] [Related]
17. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes. Baker MT; Vasquez MT; Chiang CK Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158 [TBL] [Abstract][Full Text] [Related]
18. A comparative study on reductive dehalogenation of halothane in liver, kidney and lung of the rabbit. Inoue T; Fujii K; Kikuchi H; Yuge O; Morio M Hiroshima J Med Sci; 1990 Dec; 39(4):115-8. PubMed ID: 2086561 [TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. Goeptar AR; Te Koppele JM; Lamme EK; Piqué JM; Vermeulen NP Mol Pharmacol; 1993 Dec; 44(6):1267-77. PubMed ID: 8264564 [TBL] [Abstract][Full Text] [Related]
20. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254). Morse DC; Wehler EK; Wesseling W; Koeman JH; Brouwer A Toxicol Appl Pharmacol; 1996 Feb; 136(2):269-79. PubMed ID: 8619235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]